| DESCRIPTION | HER2 OverExpress. Breast Cancer Diagnostics by Fluorescence In-Situ Hybridization |
| STATUS | FDA Approved. US Patent Expiration: 12.31.2006 |
| COMPANY | This data is not available for free |
| PATENT NUMBER | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |